Position in GSK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,074,662
-$264,744 QoQ
Shares Held
20,501
-15.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#344
of 1,033 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VeraBank, N.A. holds $15,922,408 across 9 Drug Manufacturers - General names. GSK ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,786 | $3,755,200 | |
| 2 | ABBV |
AbbVie Inc.
|
14,486 | $3,645,256 | |
| 3 | LLY |
ELI LILLY & Co
|
2,632 | $3,156,900 | |
| 4 | AMGN |
Amgen Inc
|
4,636 | $1,678,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,222 | $1,313,526 | |
| 6 | GSK |
GSK plc
This page
|
20,501 | $1,074,662 | |
| 7 | PFE |
Pfizer Inc
|
28,634 | $689,506 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,797 | $353,372 |
All Filings in GSK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,074,662 | 20,501 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,339,406 | 24,269 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,190,151 | 24,269 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,063,591 | 24,643 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,059,264 | 27,585 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||